{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:19:41Z","timestamp":1787649581858,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007063","name":"University of Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbamcr.2026.120193","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:02:57Z","timestamp":1784214177000},"page":"120193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of novel small molecule inhibitors targeting FoxM1-DNA binding domain with anti-cancer potential"],"prefix":"10.1016","volume":"1873","author":[{"given":"Pradeep Singh","family":"Cheema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeptashree","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Sahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alo","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2026.120193_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ncb1217","article-title":"FoxM1 is required for execution of the mitotic programme and chromosome stability","volume":"7","author":"Laoukili","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ncb0205-108","article-title":"FoxM1 dances with mitosis","volume":"7","author":"Costa","year":"2005","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120193_bb0015","first-page":"1","article-title":"Biology of FOXM1 and its emerging role in cancer therapy","volume":"5","author":"Jaiswal","year":"2014","journal-title":"J. Proteins Proteomics"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02483-2","article-title":"Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/emmm.201000107","article-title":"Deregulation of FoxM1b leads to tumour metastasis","volume":"3","author":"Park","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0030","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ni.3204","article-title":"The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells","volume":"16","author":"Hou","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0035","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-11-0640","article-title":"FoxM1: a master regulator of tumor metastasis","volume":"71","author":"Raychaudhuri","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2014.07.008","article-title":"FOXM1: a key oncofoetal transcription factor in health and disease","volume":"29","author":"Bella","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0045","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1158\/0008-5472.CAN-22-0410","article-title":"Transcriptional repression by FoxM1 suppresses tumor differentiation and promotes metastasis of breast cancer","volume":"82","author":"Kopanja","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0050","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1038\/s41388-022-02398-4","article-title":"FOXM1 regulates glycolysis and energy production in multiple myeloma","volume":"41","author":"Cheng","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00030","article-title":"Novel functions of FoxM1: from molecular mechanisms to cancer therapy","volume":"3","author":"Alvarez-Fern\u00e1ndez","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.08.009","article-title":"FoxM1: repurposing an oncogene as a biomarker","volume":"52","author":"Nandi","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0065","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-05-2912","article-title":"FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1101\/gad.1200704","article-title":"Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor","volume":"18","author":"Kalinichenko","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0075","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-12-3859","article-title":"Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer","volume":"73","author":"Kong","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0080","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1158\/0008-5472.CAN-05-3138","article-title":"Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice","volume":"66","author":"Kalin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0085","doi-asserted-by":"crossref","first-page":"26480","DOI":"10.18632\/oncotarget.8419","article-title":"FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0090","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1158\/0008-5472.CAN-05-3003","article-title":"The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-023-01675-8","article-title":"Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer","volume":"25","author":"Katzenellenbogen","year":"2023","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bcp.2012.10.013","article-title":"Targeting FOXM1 in cancer","volume":"85","author":"Halasi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4161\/cc.10.3.14709","article-title":"Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models","volume":"10","author":"Kalin","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13050956","article-title":"FOXM1 inhibition in ovarian cancer tissue cultures affects individual treatment susceptibility ex vivo","volume":"13","author":"Br\u00fcckner","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0115","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.2147\/CMAR.S270825","article-title":"FoxM1 is upregulated in osteosarcoma and inhibition of FoxM1 decreases osteosarcoma cell proliferation, migration, and invasion","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0120","article-title":"A lignan induces lysosomal dependent degradation of FoxM1 protein to suppress \u03b2-catenin nuclear translocation","volume":"7","author":"Dong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0125","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1158\/1078-0432.CCR-17-0901","article-title":"Targeting prostate cancer subtype 1 by Forkhead Box M1 pathway inhibition","volume":"23","author":"Ketola","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0130","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00109-014-1198-2","article-title":"Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells","volume":"92","author":"Zhang","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031761","article-title":"Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage","volume":"7","author":"Halasi","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0140","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1158\/0008-5472.CAN-06-1576","article-title":"Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1","volume":"66","author":"Radhakrishnan","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI27527","article-title":"A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment","volume":"117","author":"Gusarova","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2016.12.029","article-title":"A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression","volume":"796","author":"Bi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06056-9","article-title":"Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1","volume":"14","author":"Bu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/aps.2010.4","article-title":"Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro","volume":"31","author":"Wu","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/cgt.2014.8","article-title":"Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth","volume":"21","author":"Chen","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.751271","article-title":"Artemisinin mediates its tumor-suppressive activity in hepatocellular carcinoma through targeted inhibition of FoxM1","volume":"11","author":"Nandi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0175","article-title":"Camptothecin","volume":"62","author":"Cheema","year":"2025","journal-title":"IJBB"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0180","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1021\/acs.jmedchem.1c01069","article-title":"Targeting of the FOXM1 oncoprotein by E3 ligase-assisted degradation","volume":"64","author":"Luo","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-022-01070-w","article-title":"Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0190","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0195","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0200","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coph.2008.06.002","article-title":"Discovering and improving novel peptide therapeutics","volume":"8","author":"McGregor","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0205","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1093\/nar\/gkq194","article-title":"Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence","volume":"38","author":"Littler","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6165","article-title":"Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition","volume":"5","author":"Gormally","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0156-7","article-title":"Honokiol is a FOXM1 antagonist","volume":"9","author":"Halasi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0220","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ygyno.2012.08.036","article-title":"FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer","volume":"127","author":"He","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0225","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biocel.2014.11.002","article-title":"Oncogenic human papillomavirus 16E7 modulates SUMOylation of FoxM1b","volume":"58","author":"Jaiswal","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0230","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nchem.1114","article-title":"The transcription factor FOXM1 is a cellular target of the natural product thiostrepton","volume":"3","author":"Hegde","year":"2011","journal-title":"Nat. Chem."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-407190-2.00016-2","article-title":"FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy","volume":"119","author":"Wierstra","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0240","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/onc.2012.491","article-title":"The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment","volume":"32","author":"Monteiro","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/352478","article-title":"Prognostic value of FOXM1 in patients with malignant solid tumor: a meta-analysis and system review","volume":"2015","author":"Dai","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5732\/cjc.012.10277","article-title":"Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance","volume":"32","author":"Gomes","year":"2013","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0255","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5483\/BMBRep.2018.51.2.222","article-title":"Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1","volume":"51","author":"Roh","year":"2018","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005592","article-title":"Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells","volume":"4","author":"Bhat","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0265","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai8583","article-title":"The FOXM1 inhibitor RCM-1 suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice","volume":"10","author":"Sun","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4161\/cbt.11.1.13854","article-title":"Proteasome inhibitory activity of thiazole antibiotics","volume":"11","author":"Pandit","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01929-0","article-title":"Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies","volume":"10","author":"Raghuwanshi","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03978-0","article-title":"Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells","volume":"12","author":"Chesnokov","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0285","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1080\/07391102.2024.2308772","article-title":"Computational exploration of FOXM1 inhibitors for glioblastoma: an integrated virtual screening and molecular dynamics simulation study","volume":"43","author":"Swati","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0290","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/0115748928289164240426110829","article-title":"Structure-based virtual screening of novel FOXM1 inhibitors as potential compounds for glioblastoma treatment","volume":"20","author":"Swati","year":"2025","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0295","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4155\/fmc-2021-0282","article-title":"Structure-based virtual screening towards the discovery of novel FOXM1 inhibitors","volume":"14","author":"Xie","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1058256","article-title":"Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/1573406054864106","article-title":"Failure and success in modern drug discovery: guiding principles in the establishment of high probability of success drug discovery organizations","volume":"1","author":"GM","year":"2005","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0310","first-page":"953","article-title":"Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells","volume":"42","author":"Kongsema","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0315","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/bjc.2012.424","article-title":"The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma","volume":"107","author":"Dibb","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(01)02915-5","article-title":"Over-expression of FoxM1 stimulates cyclin B1 expression","volume":"507","author":"Leung","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0325","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1128\/MCB.25.24.10875-10894.2005","article-title":"Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase","volume":"25","author":"Wang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0330","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ydbio.2004.08.022","article-title":"The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis","volume":"276","author":"Krupczak-Hollis","year":"2004","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0335","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.4161\/cc.8.12.8708","article-title":"A novel mode of FoxM1 regulation: positive auto-regulatory loop","volume":"8","author":"Halasi","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.971045","article-title":"Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion","volume":"13","author":"Kaminskiy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35390-8","article-title":"Foxi3 transcription factor activity is mediated by a C-terminal transactivation domain and regulated by the Protein Phosphatase 2A (PP2A) complex","volume":"8","author":"Singh","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104667","article-title":"FOX transcription factors are common regulators of Wnt\/\u03b2-catenin\u2013dependent gene transcription","volume":"299","author":"Moparthi","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01936-1","article-title":"FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0360","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0938-x","article-title":"The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis","volume":"18","author":"Laissue","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120193_bb0365","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.acthis.2012.01.002","article-title":"FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer","volume":"114","author":"Chu","year":"2012","journal-title":"Acta Histochem."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0370","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-12-134","article-title":"Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer","volume":"12","author":"Wen","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0375","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbamcr.2026.120193_bb0380","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1073\/pnas.1505979112","article-title":"Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation","volume":"112","author":"Rotem","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:30:16Z","timestamp":1787646616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0167488926000923"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120193","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and validation of novel small molecule inhibitors targeting FoxM1-DNA binding domain with anti-cancer potential","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120193"}}